{"title":"[SYSTEMIC PHARMACOLOGICAL TREATMENT OF PAIN IN RHEUMATIC DISEASE].","authors":"Simeon Grazio, Ines Doko","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Pain is a cardinal symptom of rheumatic diseases and the most common reason for seeking medical\nhelp. Pain relief has many benefi cial eff ects and is necessary for the functional recovery. A variety of drugs are used for\nthe treatment of pain in rheumatic diseases. Th ey usually include acetaminophen, nonsteroidal anti-rheumatic drugs,\nand opioids (mostly weak opioids). Antidepressants and anticonvulsants can be used in cases with a predominant\nneuropathic component. In this descriptive review we present up-to-date results of trials with systemic analgesic drugs\nin rheumatic diseases, including nerve growth factor inhibitors and symptomatic slow-acting drugs for osteoarthritis.</p>","PeriodicalId":76426,"journal":{"name":"Reumatizam","volume":"63 Suppl 1 ","pages":"39-46"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reumatizam","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Pain is a cardinal symptom of rheumatic diseases and the most common reason for seeking medical
help. Pain relief has many benefi cial eff ects and is necessary for the functional recovery. A variety of drugs are used for
the treatment of pain in rheumatic diseases. Th ey usually include acetaminophen, nonsteroidal anti-rheumatic drugs,
and opioids (mostly weak opioids). Antidepressants and anticonvulsants can be used in cases with a predominant
neuropathic component. In this descriptive review we present up-to-date results of trials with systemic analgesic drugs
in rheumatic diseases, including nerve growth factor inhibitors and symptomatic slow-acting drugs for osteoarthritis.